LYNPARZA® Recommended for Approval in EU by CHMP as First-Line Maintenance Treatment with Bevacizumab for HRD-Positive Advanced Ovarian Cancer Pharmaceutical Investing
Thoughtful Brands Enters Binding Term Sheet to Acquire American CBD Extraction Corp. Cannabis Investing News
New Wave Holdings Corp Appoints Daniel Fox as Chief Executive Officer and Diego Gianelli as a Director Psychedelics Investing
Better Plant Sciences Announces Wright & Well Packaging Acclaimed by Leading Design Publications Cannabis Investing News
BriaCell Announces ESMO 2026 Poster Highlighting Circulating Immune Biomarker Associated with Clinical Outcomes in Metastatic Breast Cancer
Marvel Biosciences Advances MB-204 Toward First-in Human Testing, Selects CMAX as Phase I Clinical Trial Site
